Level C· Early human research exploring benefitsProspective StudyPubMed

Exploring the role of cellular plasticity in metabolic dysfunction-associated steatosis and related molecular mechanisms.

Ercin M., Gezginci-Oktayoglu S.

Prospective Study on Type 2 Diabetes, published in J Transl Med (2025) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Prospective Study
Journal
J Transl Med (2025)
Country
England
Reported sample size
—
Source database
PubMed
PMID
41233849
DOI
10.1186/s12967-025-06922-4

Abstract (original English)

In chronic diseases, hepatocytes may dedifferentiate and form a liver progenitor cell (LPC)-like population in response to long-term stress stimuli. We investigated the hypothesis that hepatocytes may dedifferentiate upon chronic high insulin stimulation and subsequently form adipocytes and/or fibroblast-like cells as a result of long-term fatty acid exposure. HepG2 cells were treated with prolonged high insulin followed by oleic acid (OA). The expression level of LPC, adipocyte and fibroblast marker genes was measured. Populations of cells carrying the LPC marker CD34, the fibroadipogenic progenitor cell marker PDGFR1α and the activated fibroblast marker FAPα were detected. Lipid accumulation and the existence of the adipocyte marker perilipin-A were shown. The relevant molecular mechanism was investigated by applying specific inhibitors and determining related protein levels. With high insulin exposure, the number of CD34 + or PDGFR1α + cells and the gene expression levels of LPC markers increased, whereas the gene expression of hepatocyte markers decreased. Lipid accumulation, adipogenesis and adipocyte marker gene expression levels and the density of Perilipin-A increased in cells treated with OA following high insulin. On the other hand, in cells treated with OA alone or OA following insulin, the expression levels of fibroblast marker genes and the FAPα + cell population w

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence
HumansHep G2 CellsCell PlasticityFatty LiverHepatocytesInsulinAdipocytesLipid MetabolismOleic AcidGene Expression Regulation

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research